Structural insight into substrate specificity and regulatory mechanisms of phosphoinositide 3-kinases

Trends in Biochemical Sciences

Volumn 27, Issue 8, 2002, Pages 426-432

  Djordjevic, Snezana ^a   Driscoll, Paul C ^a,b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b LUDWIG INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GUANOSINE TRIPHOSPHATASE; INOSITOL; LIPID; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOTRANSFERASE INHIBITOR; PROTEIN; PROTEIN KINASE; PROTEIN P21; PROTEIN RBD; RAS PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CATALYSIS; CELLULAR PARAMETERS; DRUG DESIGN; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME BINDING; ENZYME REGULATION; ENZYME SPECIFICITY; ENZYME STRUCTURE; ENZYME SUBUNIT; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN FAMILY; REGULATORY MECHANISM; STRUCTURE ANALYSIS;

EID: 0036683691     PISSN: 09680004     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-0004(02)02136-9     Document Type: Review

References (51)

1. Structural insights into phosphoinositide 3-kinase catalysis and signalling
2. Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine
3. Crystal structure and functional analysis of Ras binding to its effector phosphoinositide 3-kinase γ
4. Signalling by distinct classes of phosphoinositide 3-kinases
5. PI3-kinase inhibition: A target for drug development?
6. The Drosophila phosphoinositide 3-kinase Dp110 promotes cell growth
7. Regulation of imaginal disc cell size, cell number and organ size by Drosophila class I(A) phosphoinositide 3-kinase and its adaptor
8. The conserved phosphoinositide 3-kinase pathway determines heart size in mice
9. Central role for G protein-coupled phosphoinositide 3-kinase γ in inflammation
10. Roles of PLC-β2 and -β3 and PI3Kγ in chemoattractant-mediated signal transduction
11. Function of PI3Kγ in thymocyte development, T cell activation, and neutrophil migration
12. Resistance to thromboembolism in PI3Kγ-deficient mice
13. Increased levels of phosphatidylinositol 3-kinase activity in colorectal tumors
14. Phospatidylinositol 3-kinase expression in human breast cancer
15. A family of putative tumour suppressors is structurally and functionally conserved in humans and yeast
16. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers
17. P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase
18. Phosphoinositide 3-kinase is activated by phosphopeptides that bind to the SH2 domains of the 85-kDa subunit
19. Cloning and characterization of a G protein-activated human phosphoinositide-3 kinase
20. Class II phosphoinositide 3-kinases are downstream targets of activated polypeptide growth factor receptors
21. Characterizing the interactions between the two subunits of the p101/p110γ phosphoinositide 3-kinase and their role in the activation of this enzyme by Gβγ subunits
22. PI 3-kinase is a dual specificity enzyme: Autoregulation by an intrinsic protein-serine kinase activity
23. Bifurcation of lipid and protein kinase signals of PI3Kγ to the protein kinases PKB and MAPK
24. Activation loop sequences confer substrate specificity to phosphoinositide 3-kinase α (PI3Kα)
25. Vps34p required for yeast vacuolar protein sorting is a multiple specificity kinase that exhibits both protein kinase and phosphatidylinositol-specific PI 3-kinase activities
26. Specificity and mechanism of action of some commonly used protein kinase inhibitors
27. Structure of importin-β bound to the IBB domain of importin-α
28. Structural view of the Ran-Importin β interaction at 2.3 Å resolution
29. The structure of the protein phosphatase 2A PR65/A subunit reveals the conformation of its 15 tandemly repeated HEAT motifs
30. A ternary metal binding site in the C2 domain of phosphoinositide-specific phospholipase C-δ1
31. Phox domain interaction with PtdIns(3)P targets the Vam7 t-SNARE to vacuole membranes
32. Phox homology domains specifically bind phosphatidylinositol phosphates
33. Human phosphoinositide 3-kinase C2β, the role of calcium and the C2 domain in enzyme activity
34. Localization of a class II phosphatidylinositol 3-kinase, PI3KC2α, to clathrin-coated vesicles
35. The class II phosphoinositide 3-kinase PI3K-C2α is concentrated in the trans-Golgi network and present in clathrin-coated vesicles
36. Phosphatidyl-3-OH kinase as a direct target of Ras
37. Activation of phosphoinositide 3-kinase by interaction with Ras and by point mutation
38. Interaction of Ras with phosphoinositide 3-kinase γ
39. The activation of phosphatidylinositol 3-kinase by Ras
40. Regulation of Ras signaling by the cell cycle
41. The 2.2 Å crystal structure of the Ras-binding domain of the serine/threonine kinase c-Raf1 in complex with Rap1A and a GTP-analogue
42. Structural basis for the interaction of Ras with RalGDS
43. Different structural requirements within the switch II region of the Ras protein for interactions with specific downstream targets
44. The crystal structure of the PX domain from P40Phox bound to phosphatidylinositol 3-phosphate
45. Crystal structure of PI3K SH3 domain at 2.0 Å resolution
46. Solution structure and ligand-binding site of the SH3 domain of the p85 α subunit of phosphatidylinositol 3-kinase
47. Crystal structure of the breakpoint cluster region-homology domain from phosphoinositide 3-kinase p85 α subunit
48. Structure of an SH2 domain of the p85 α subunit of phosphatidylinositol-3-OH kinase
49. NMR structure of the N-SH2 of the p85 subunit of phosphoinositide 3-kinase complexed to a doubly phosphorylated peptide reveals a second phosphotyrosine binding site
50. Solution structure of the C-terminal SH2 domain of the p85 α regulatory subunit of phosphoinositide 3-kinase
51. NMR trial models: Experiences with the colicin immunity protein Im7 and the p85α C-terminal SH2-peptide complex